Cantharidin-mediated ultrastructural and biochemical changes in mitochondria lead to apoptosis and necrosis in murine dalton's lymphoma

Microscopy and Microanalysis

Volumn 19, Issue 6, 2013, Pages 1377-1394

  Prasad, Surya B ^a   Verma, Akalesh K ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

apoptosis; cantharidin; Dalton's lymphoma; mitochondria; ultrastructure

Indexed keywords

ANTINEOPLASTIC AGENT; CANTHARIDIN;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; LYMPHOMA; MITOCHONDRION; MOUSE; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CANTHARIDIN; LYMPHOMA; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA;

EID: 84887972703     PISSN: 14319276     EISSN: 14358115     Source Type: Journal    
DOI: 10.1017/S143192761301324X     Document Type: Article

References (66)

1. AJITH, T.A. & JANARDHANAN, K.K. (2003). Cytotoxic and antitumor activities of a polypore macrofungus, Phellinusrimosus (Berk) Pilat. J Ethnopharmacol 84, 157-162.
2. BAUMBACH, J.L. & SHETH, P.B. (2001). Topical and intralesional antiviral agents. In Comprehensive Dermatologic Drug Therapy, Wolverton, S.E. (Ed.), pp. 524-536. Philadelphia, PA: W. B. Saunders Company.
3. 2+ by liver mitochondria. J Biol Chem 259, 1279-1281.
4. BIASUTTO, L., SASSI, N., MATTAREI, A., MAROTTA, E., CATTELAN, P., TONINELLO, A., GARBISA, S., ZORATTI, M. & PARADISI, C. (2010). Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim Biophy Acta 1797, 189-196.
5. COTOVIO, P., SILVA, C, MARQUES, M.G., FERRER, F., COSTA, F., CARREIRA, A. & CAMPOS, M. (2013). Acute kidney injury by cantharidin poisoning following a silly bet on an ugly beetle. Clin Kidney J 6, 201-203.
6. DUMAS, J.F., ROUSSEL, D. & SERVAIS, S. (2012). Mitochondria and cancer, chapter 4,. In Cellular Bioenergetics in Health and Diseases: New Perspectives in Mitochondrial Biology, ISBN: 978-81-308-0487-3, Lou, PH. & Petersen, N. (Eds.), pp. 115-147. Trivandrum, India: Research Signpost.
7. ESTRELA, J.M., HERNANDEZ, R., TERRADEZ, P., ASENSI, M., PUER-TES, I.R. & VINA, J. (1992). Regulation of glutathione metabolism in Ehrlich ascites tumour cells. Biochem J 286, 257-262.
8. FRANKLIN, D.J., BRUSSAARD, C.P.D. & BERGES, J.A. (2006). What is the role and nature of programmed cell death in phytoplank-ton ecology? Eur J Phycol 41, 1-14.
9. FULDA, S., GALLUZZI, L. & KROEMER, G. (2010). Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9, 447-464.
10. GOLDIE, H. & FELIX, M.D. (1951). Growth characteristics of free tumor cells transformed serially in the peritoneal fluid of the mouse. Cancer Res 11, 73-80.
11. GOMES, A., BHATTACHARJEE, P., MISHRA, R., BISWAS, A.K., DAS-GUPTA, S.C. & GIRI, B. (2010). Anticancer potential of animal venoms and toxins. Indian J Expt Biol 48, 93-103.
12. GRAZIANO, M.J., WATERHOUSE, A.L. & CASIDA, J.E. (1987). Cantharidin poisoning associated with specific binding site in liver. Biochem Biophys Res Commun 149, 79-85.
13. HONKANEN, R.E. (1993). Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett 330, 283-286.
14. HUAN, S.K., LEE, H.H., LIU, D.Z., WU, C.C. & WANG, C.C. (2006). Cantharidin induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line. Toxicology 223, 136-143.
15. HUANG, W., KO, S., TSAI, H., CHUNG, J., CHIANG, J., CHEN, K., CHEN, Y., CHEN, H., CHEN, U. & YANG, J. (2011). Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol 38, 1067-1073.
16. JOLLOW, D.J., MITCHELL, J.R., ZAMPAGLIONE, N. & GILLETTE, J.R. (1974). Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 11, 151-169.
17. KARNA, P., ZUGHAIER, S., PANNU, V., SIMMONS, R., NARAYAN, S. & ANEJA, R. (2010). Induction of reactive oxygen species-mediated autophagy by a novel microtubule-modulating agent. J Biol Chem 285, 18737-18748.
18. KIM, J.W. & DANG, C.V. (2006). Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66, 8927-8930.
19. KIM, M., COOPER, D.D., HAYES, S.F. & SPANGRUDE, G.J. (1998). Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 91, 4106-4117.
20. KING, A., SELAK, M.A. & GOTTLIEB, E. (2006). Succinate dehydrog-enase and fumaratehydratase: Linking mitochondrial dysfunction and cancer. Oncogene 25, 4675-4682.
21. KOUKOURAKIS, M., GIATROMANOLAKI, A., HARRIS, A.L. & SIVRI-DIS, E. (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor associated stroma. Cancer Res 66, 632-637.
22. KROEMER, G., GALLUZZI, L. & BRENNER, C. (2007). Mitochondrial membrane permeabilization in cell death. Physiol Rev 87, 99-163.
23. KUO, J.H., CHU, Y.L., YANG, J.S., LIN, J.P., LAI, K.C., KUO, H.M., HSIA, T.C. & CHUNG, J.G. (2010). Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways. Int J Oncol 37, 1243-1250.
24. KUSAO, I., TROELSTRUP, D. & SHIRAMIZU, B. (2008). Possible mitochondria associated enzymatic role in non-Hodgkin lym-phoma residual disease. Cancer Growth Metastasis 1, 3-8.
25. 3-induced oxidative stress and cycle progression in a human intestinal epithelial cell line (Caco-2). Toxicol. In Vitro 22, 444-449.
26. LE-QUOC, K. & LE-QUOC, D. (1989). Relationships between the NAD (P) redox state, fatty acid oxidation and inner membrane permeability in rat liver mitochondria. Arch Biochem Biophys 273, 466-478.
27. LIAO, H., CHEN, Y., CHOU, C., WANG, F. & CHENG-DENG KUO, C. (2011). Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production. Toxicol. In Vitro 25, 206-212.
28. LIU, D., SHI, P., YIN, X., CHEN, Z. & ZHANG, X. (2012). Effect of norcantharidin on the human breast cancer Bcap-37 cells. Connect Tissue Res 53, 508-512.
29. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
30. MAJNO, G. & JORIS, I. (1995). Apoptosis, oncosis, and necrosis an overview of cell death. Am J Pathol 146, 1-15
31. MARTHA, K.R.M., ROSANGKIMA, G., LONGCHAR, A., RONGPI, T. & PRASAD, S.B. (2013). Cisplatin-and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice. Fund Clin Pharmacol 27, 329-338.
32. MCKENZIE, D. & HENDERSON, A.R. (1983). Electrophoresis of lactate dehydrogenase isoenzymes. Clin Chem 29, 189-195.
33. MEISTER, A. & ANDERSON, M.E. (1983). Glutathione. Ann Rev Biochem 52, 711-760.
34. MIGNOTTE, B. & VAYSSIERE, J. (1998). Mitochondria and apopto-sis. Eur J Biochem 252, 1-15.
35. MODICA-NAPOLITANO, J.S. & SINGH, K.K. (2004). Mitochondrial dysfunction in cancer. Mitochondrion 4, 755-762.
36. MURPHY, M.P. & SMITH, R.A.J. (2000). Drug delivery to mitochondria: The key to mitochondrial medicine. Adv Drug Deliv Rev 41, 235-250.
37. NIRMALA, J.M., SAMUNDEESWARI, A. & SANKAR, P.D. (2011). Natural plant resources in anti-cancer therapy-A review. Res Plant Biol 1, 1-14.
38. PAMPLONA, R., PRAT, J., CADENAS, S., ROJAS, C., PEREZ-CAMPO, R., LOPEZ TORRES, M. & BARJA, G. (1996). Low fatty acid unsatu-ration protects against lipid peroxidation in liver mitochondria from long-lived species, the pigeon and human case. Mech Aging Dev 86, 53-66.
39. PETIT, P.X., LE COVER, H., ZORN, H., DAUGET, C., MIGNOTTE, B. & GOUGEON, M.L. (1995). Alteration of mitochondrial structure and function are early events of dexamethasone-induced thy-mocyte apoptosis. J Cell Biol 130, 156-167.
40. PORTER, N.A., CALDWELL, S.E. & MILLS, K.A. (1995). Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290.
41. PRASAD, S.B., ROSANGKIMA, G. & KHARBANGAR, A. (2010b). Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice. Mitochondrion 10, 38-45.
42. PRASAD, S.B., VERMA, A.K., ROSANGKIMA, G., BRAHMA, B., RONGPI, T., AMENLA & ARJUN, J. (2010a). Antitumor activity of Mylabris cichorii extracts against murine ascites Dalton's lymphoma. J Pharmacy Res 3, 3006-3009.
43. ROLFE, D.F.S. & BROWN, G.C. (1997). Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77, 731-758.
44. SHAW, J.P. & CHOU, I.N. (1986). Elevation of intracellular glutathi-one content associated with mitogenic stimulation of quiescent fibroblasts. J Cell Physiol 129, 193-198.
45. SIEDER, S., RICHTER, E., BECKER, K., HEINS, R. & STEINFELDER, H.J. (1999). Doxorubicin resistant LoVo adenocarcinoma cells display resistance to apoptosis induction by some but not all inhibitors of ser/thr phosphatases 1 and 2A. Toxicology 134, 109-115.
46. STEWART, B.W. & KLEIHUES, P. (EDS.) (2003). World Cancer Report. Lyon, France: IARC Press.
47. SUN, X., LIAO, N.K. & YU, J.J. (2012). Prognostic value of a mitochondrial functional score in prostate cancer. J Int Med Res 40, 371-376.
48. TERRADEZ, P., ASENSI, M., LASSO DE LA VEGA, M.C., PUERTES, I., VINA, J. & ESTRELA, J.M. (1993). Depletion of tumor glutathi-one in vivo by buthionine sulfoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth. Bio-chem J 292, 477-483.
49. THOMSEN, R. & CHRISTENSEN, M.H. (2006). MolDock: A new technique for high-accuracy molecular docking. J Med Chem 49, 3315-3321.
50. TSAUER, W., LIN, J.G., LIN, P.Y., HSU, F.L. & CHIANG, H.C. (1997). The effects of cantharidin analogues on xanthine oxidase. Anticancer Res 17, 2095-2098.
51. VERMA, A.K. & PRASAD, S.B. (2012). Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma. Cell Biol Toxicol 28, 133-147.
52. VERMA, A.K. & PRASAD, S.B. (2013). Changes in glutathione, oxidative stress and mitochondrial membrane potential in apop-tosis involving the anticancer activity of cantharidin isolated from redheaded blister beetles, Epicauta hirticornis. Anticancer Agents Med Chem 13, 1096-1114.
53. VERMA, A.K., PRASAD, S.B., KALIYAPPAN, R.K. & ARJUN, J. (2013). Crystal structure of cantharidin (2, 6-dimethyl-4, 10-dioxa-tricyclo-[5.2.1.02, 6] decane-3, 5-dione) isolated from redheaded blister beetle, Epicauta hirticornis. IntJ Bioassays 2, 527-530.
54. WALENTA, S., SNYDER, S., HAROON, Z.A., BRAUN, R.D., AMIN, K., BRIZEL, D., MUELLER-KLIESER, W., CHANCE, B. & DEWHIRST, M.W. (2001). Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. IntJRadiat Oncol Biol Phys 51, 840-848.
55. WALLACE, C.A., LASKOWSKI, A.R. & THORNTON, M.J. (1995). LIG-PLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8, 127-134.
56. WANG, C.C., HSIEH, K.J., YEN, K.Y. & YANG, L.L. (2000). Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 147, 77-87.
57. WANG, G.S. (1989). Medical uses of Mylabris in ancient China and recent studies.J Ethnopharmacol 26, 147-162.
58. WARBURG, O. (1956). On the origin of cancer of cells. Science 123, 309-314.
59. HEMMINGS, B.A. (1995). Serine/threonine protein phosphatases. Biochem J 311, 17-29.
60. WORLD HEALTH ORGANIZATION (WHO) (2008). Traditional Medicine Fact Sheet No. 134. Available at www.who.int/mediacentre/factsheets/fs134/en/.
61. WRIGHT, J.R., COLBY, H.D. & MILES, P.R. (1981). Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 206, 296-304.
62. YAO, X., PANICHPISAL, K., NEILKURTZMAN, N. & NUGENT, K. (2007). Cisplatin nephrotoxicity: A review. Am J Med Sci 334, 115-124.
63. YEH, C., YANG, Y., HUANG, Y., CHOW, K. & CHEN, M. (2012). Induction of apoptosis in human Hep3B Hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction. Chin J Integr Med 18, 676-682.
64. ZAMBLE, B.D. & LIPPARD, S.J. (1995). Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20, 435-439.
65. ZEISS, C.J. (2003). The apoptosis-necrosis continuum: Insights from genetically altered mice. Vet Pathol 40, 481-495.
66. ZHANG, J.P., YING, K., XIAO, Z.Y., ZHOU, B., HUANG, Q.S., WU, H.M., YIN, M., XIE, Y., MAO, Y.M. & RUI, Y.C. (2004). Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarray. Int J Cancer 108, 212-218.